tirzepatide
Peptide Products Ltd Company No
5-12 The most common patient-reported adverse effects (AEs) associated with GLP-1 RAs and dual GIP/GLP-1 RAs are gastrointestinal (GI) in nature and may include abdominal pain, constipation, diarrhea, nausea, and vomiting
Rare (may affect up to 1 in 1,000 people): severe allergic reaction accompanied by symptoms such as difficulty breathing, low blood pressure, shortness of breath, pressure and pain in the chest, rash, itching, swelling of the lips, tongue, face, severe weakness or other signs of a sharp deterioration in health (anaphylactic reaction)
J., Lane, M
It is the default survival mechanism humans relied on for thousands of years before agriculture made carbohydrates constantly available